Literature DB >> 12591203

Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virus.

William L Mengeling1, Kelly M Lager, Ann C Vorwald, Kenneth J Koehler.   

Abstract

The primary objective of the study was to determine strain specificity of the immune response of pigs following vaccination with selected strains of porcine reproductive and respiratory syndrome virus (PRRSV). The experimental design included five groups (I through V, six pigs per group) free of antibody for PRRSV at the beginning of the experiment (day 0). On day 0, groups III, IV, and V were vaccinated with attenuated versions of PRRSV strains 8, 9, and 14, respectively. On day 21, the immunity of group II (non-vaccinated/challenged controls) and groups III, IV, and V was challenged by exposing each pig to a composite of the virulent versions of these same three strains. On day 35, all pigs, including non-vaccinated/non-challenged pigs of group I, were necropsied. Lungs and selected lymph nodes were examined for lesions. Serum samples obtained at weekly intervals throughout the study and lung lavage fluids obtained at necropsy were tested for the presence of PRRSV and its strain identity. Before challenge the strain of PRRSV identified in the sera of vaccinated pigs was always that with which the particular pig had been vaccinated (i.e. homologous strain), whereas, with one exception, only heterologous strains were identified after challenge. This apparent strain exclusion as a result of vaccination was statistically significant (P = 0.004). The tendency for heterologous strains to predominate after challenge suggests that a pig's immune response to PRRSV has some degree of strain specificity. Whether this finding has any clinical relevance in regard to immunoprophylaxis remains to be determined. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12591203     DOI: 10.1016/s0378-1135(02)00427-3

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  29 in total

1.  Analysis of immunogenicity of minor envelope protein GP3 of porcine reproductive and respiratory syndrome virus in mice.

Authors:  Wenming Jiang; Ping Jiang; Yufeng Li; Xianwei Wang; Yijun Du
Journal:  Virus Genes       Date:  2007-08-01       Impact factor: 2.332

Review 2.  Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects.

Authors:  Wasin Charerntantanakul
Journal:  World J Virol       Date:  2012-02-12

3.  North American porcine reproductive and respiratory syndrome viruses inhibit type I interferon production by plasmacytoid dendritic cells.

Authors:  Gabriela Calzada-Nova; William M Schnitzlein; Robert J Husmann; Federico A Zuckermann
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

4.  Assessment of the safety and efficacy of an attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus.

Authors:  Xiuling Yu; Zhi Zhou; Zhen Cao; Jiajun Wu; Zhongqiu Zhang; Baiwan Xu; Chuanbin Wang; Dongmei Hu; Xiaoyu Deng; Wei Han; Xiaoxue Gu; Shuo Zhang; Xiaoxia Li; Baoyue Wang; Xinyan Zhai; Kegong Tian
Journal:  Clin Vaccine Immunol       Date:  2015-03-04

5.  Safety and early onset of immunity with a novel European porcine reproductive and respiratory syndrome virus vaccine in young piglets.

Authors:  Michael Piontkowski; Jeremy Kroll; Christian Kraft; Teresa Coll
Journal:  Can J Vet Res       Date:  2016-04       Impact factor: 1.310

6.  Enhanced humoral and cellular immune responses to PRRS virus GP5 glycoprotein by DNA prime-adenovirus boost vaccination in mice.

Authors:  Meifang Yu; Yuan Qiu; Jiming Chen; Wenming Jiang
Journal:  Virus Genes       Date:  2016-02-02       Impact factor: 2.332

7.  Characterization of homologous and heterologous adaptive immune responses in porcine reproductive and respiratory syndrome virus infection.

Authors:  Ivan Díaz; Mariona Gimeno; Laila Darwich; Nuria Navarro; Liudmila Kuzemtseva; Sergio López; Ivan Galindo; Joaquim Segalés; Margarita Martín; Joan Pujols; Enric Mateu
Journal:  Vet Res       Date:  2012-04-19       Impact factor: 3.683

8.  Predicted peptides from non-structural proteins of porcine reproductive and respiratory syndrome virus are able to induce IFN-γ and IL-10.

Authors:  Alexel Burgara-Estrella; Ivan Díaz; Irene M Rodríguez-Gómez; Sabine E Essler; Jesús Hernández; Enric Mateu
Journal:  Viruses       Date:  2013-02-11       Impact factor: 5.048

9.  The M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner.

Authors:  Wander Van Breedam; Hanne Van Gorp; Jiquan Q Zhang; Paul R Crocker; Peter L Delputte; Hans J Nauwynck
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

10.  Biodegradable nanoparticle-entrapped vaccine induces cross-protective immune response against a virulent heterologous respiratory viral infection in pigs.

Authors:  Varun Dwivedi; Cordelia Manickam; Basavaraj Binjawadagi; Dechamma Joyappa; Gourapura J Renukaradhya
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.